Evidence map›Paper›PMID 22206986›Full record

ArticleJournal of molecular biology2012

Molecular structure and peptidoglycan recognition of Mycobacterium tuberculosis ArfA (Rv0899).

Yong Yao, Neha Barghava, Johnny Kim, Michael Niederweis, Francesca M Marassi

Abstract read
In one paragraph

Article in Journal of molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Transboundary and emerging diseases · 2024
    Article
  4. Molecular Identification and Acid Stress Response of anInternational journal of molecular sciences · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Structure of CrgA, a cell division structural and regulatory protein from Mycobacterium tuberculosis, in lipid bilayers.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  9. Article
  10. Updating and curating metabolic pathways of TB.Tuberculosis (Edinburgh, Scotland) · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yong YaoSanford Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Neha Barghava
Johnny Kim
Michael Niederweis
Francesca M Marassi
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of Alabama at Birmingham · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Maximiliano A DAngelo · 1985 to 2026
$107.2M
Target IdentificationP01AI074805 · NIAID · FLORIDA STATE UNIVERSITY · PI CROSS, TIMOTHY A · 2009 to 2013
$8.7M
Acquisition of a Cryoprobe for an 800 MHz NMR SpectrometerS10RR023773 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OPELLA, STANLEY J · 2008 to 2008
$237k
NCI NIH HHS CA030199NCI NIH HHS P30 CA030199NCRR NIH HHS S10 RR023773NCRR NIH HHS S10RR23773NIAID NIH HHS AI074805NIAID NIH HHS P01 AI074805
6 · The paper itself

Abstract

Mycobacterium tuberculosis ArfA (Rv0899) is a membrane protein encoded by an operon that is required for supporting bacterial growth in acidic environments. Its C-terminal domain (C domain) shares significant sequence homology with the OmpA-like family of peptidoglycan-binding domains, suggesting that its physiological function in acid stress protection may be related to its interaction with the mycobacterial cell wall. Previously, we showed that ArfA forms three independently structured modules, and we reported the structure of its central domain (B domain). Here, we describe the high-resolution structure and dynamics of the C domain, we identify ArfA as a peptidoglycan-binding protein and we elucidate the molecular basis for its specific recognition of diaminopimelate-type peptidoglycan. The C domain of ArfA adopts the characteristic fold of the OmpA-like family. It exhibits pH-dependent conformational dynamics (with significant heterogeneity at neutral pH and a more ordered structure at acidic pH), which could be related to its acid stress response. The C domain associates tightly with polymeric peptidoglycan isolated from M. tuberculosis and also associates with a soluble peptide intermediate of peptidoglycan biosynthesis. This enabled us to characterize the peptidoglycan binding site where five highly conserved ArfA residues, including two key arginines, establish the specificity for diaminopimelate- but not Lys-type peptidoglycan. ArfA is the first peptidoglycan-binding protein to be identified in M. tuberculosis. Its functions in acid stress protection and peptidoglycan binding suggest a link between the acid stress response and the physicochemical properties of the mycobacterial cell wall.

Indexed as

Bacterial Outer Membrane ProteinsBinding SitesCrystallography, X-RayDiaminopimelic AcidHydrogen-Ion ConcentrationModels, MolecularMycobacterium tuberculosisPeptidoglycanProtein ConformationBacterial Outer Membrane ProteinsDiaminopimelic AcidPeptidoglycan

Identifiers

PMID22206986
PMCPMC3269530
OpenAlexW2037873150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.